Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of a Higher Dose on the Pharmacokinetics of 17-alpha Hydroxyprogesterone Caproate in Obese Women

NCT03433040 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.

NCT NCT03433040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03433040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of a Higher Dose on the Pharmacokinetics of 17-alpha Hydroxyprogesterone Caproate in Obese Women
Lead sponsor
University of South Florida
Phase
Phase 3
Overall status
Completed
Start date
August 23, 2017
Completion date
July 14, 2021
Enrollment
44 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

absorption; chemicals, premature birth